Iovance Biotherapeutics (IOVA) Current Leases (2019 - 2026)
Iovance Biotherapeutics (IOVA) posted quarterly Current Leases of $2.9 million for Q1 2026, down 65.89% year-over-year from $8.5 million in Q1 2025, and down 28.3% quarter-over-quarter from $4.0 million in Q4 2025.
Iovance Biotherapeutics (IOVA) Current Leases (2019 - 2026) Analysis & Trends
Iovance Biotherapeutics (IOVA) has reported Current Leases for 8 consecutive years, with $2.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases fell 65.89% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $2.9 million (down 65.89% YoY), while the FY2025 annual figure was $4.0 million, down 68.65% from the prior year.
- Current Leases retreated to $2.9 million in Q1 2026 per IOVA's latest filing, from $4.0 million in the prior quarter.
- Across five years, Current Leases topped out at $12.9 million in Q4 2024 and bottomed at $2.9 million in Q1 2026.
- Historically, Current Leases has averaged $8.6 million across 5 years, with a median of $7.8 million in 2023.
- Annual changes were most pronounced in 2022 — Current Leases surged 148.9% — and 2025, when it plunged 68.65%.
- Iovance Biotherapeutics' Current Leases stood at $12.6 million in 2022, then sank by 38.21% to $7.8 million in 2023, then soared by 65.82% to $12.9 million in 2024, then slumped by 68.65% to $4.0 million in 2025, then slipped by 28.3% to $2.9 million in 2026.
- Business Quant data shows IOVA's Current Leases at $2.9 million in Q1 2026, $4.0 million in Q4 2025, and $6.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Iovance Biotherapeutics | 3.16 Bn | 2.86 Bn | 55.72 Mn | 2.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.67 Mn |
| Mar 31, 2026 | 2.90 Mn |
| Dec 31, 2025 | 4.04 Mn |
| Sep 30, 2025 | 6.28 Mn |
| Jun 30, 2025 | 7.07 Mn |
| Mar 31, 2025 | 8.50 Mn |
| Dec 31, 2024 | 12.90 Mn |
| Mar 31, 2024 | 11.08 Mn |
| Dec 31, 2023 | 7.78 Mn |
| Sep 30, 2023 | 10.47 Mn |
| Jun 30, 2023 | 10.87 Mn |
| Mar 31, 2023 | 12.61 Mn |
| Dec 31, 2022 | 12.59 Mn |
| Sep 30, 2022 | 7.17 Mn |
| Jun 30, 2022 | 6.48 Mn |
| Mar 31, 2022 | 7.71 Mn |
| Dec 31, 2021 | 5.06 Mn |
| Sep 30, 2021 | 6.62 Mn |
| Jun 30, 2021 | 4.43 Mn |
| Mar 31, 2021 | 5.92 Mn |